In contrast to moderate tumor volume changes, we observed a robust reduction in proportion of LGR5+ (3-fold) as well as CXCR4+ cells in OSI-906 treated xenografts compared to vehicle treated controls (Fig. 6C). The gene discussed is LGR5; the disease is neoplasm.